Clinical Trials Directory

Trials / Completed

CompletedNCT05648435

Lithium Clearance in Patients With High Risk of Acute Kidney Injury

Proximal Tubule Function in Septic Patients as Measured by Endogenous Lithium Clearance

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
University Hospital of North Norway · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

Renal lithium clearance is hypothesized to be a useful indicator of renal tubular function. In this study lithium clearance will be monitored in patients with sepsis associated acute kidney injury and in healthy controls.

Detailed description

Lithium is almost completely reabsorbed in the proximal tubule in parallel with sodium and water. What is not reabsorbed here is assumed to be fully excreted in urine, giving a reasonably accurate measurement of sodium reabsorption in the proximal tubule. Endogenous lithium clearance will be measured by inductively coupled plasma mass spectrometry (ICP-MS). The Gomez equations will be applied to calculate efferent arteriolar resistance, afferent arteriolar resistance, glomerular hydrostatic pressure, glomerular filtration pressure, and glomerular oncotic pressure. N-acetyl-β-D glucosaminidase (NAG) and NGAL, markers of tubular injury, will be measured by a spectrophotometric method using a commercially available kit. Routine blood and urine analyses will be performed at the Diagnostic Clinic Laboratory, University Hospital of North Norway, Tromsø.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLithium measuresMeasurements of lithium levels in blood and urine

Timeline

Start date
2022-12-07
Primary completion
2023-01-31
Completion
2023-01-31
First posted
2022-12-13
Last updated
2023-04-12

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05648435. Inclusion in this directory is not an endorsement.